Together, these data demonstrate that reduction of BARD1 in Ewing sarcoma: (i) enhances sensitivity to both talazoparib and niraparib, (ii) leads to increased apoptosis in the setting of PARPi plus direct DNA damage (radiation). This evidence concerns the gene BARD1 and Ewing sarcoma.